Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Dezember 2025 09:29 ET | Quelle: NeXtGen Biologics

NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review

NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review
28. September 2023 11:15 ET | Quelle: Synlogic, Inc.

Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism

CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
21. September 2023 07:00 ET | Quelle: Synlogic, Inc.

Synlogic to Participate in Chardan’s Genetic Medicines Conference

CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
19. September 2023 11:00 ET | Quelle: Synlogic, Inc.

Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100

CAMBRIDGE, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
24. Mai 2022 10:00 ET | Quelle: EVEXIAS Health Solutions

Dr. Gary Donovitz, Founder of BioTE, Provides Public Apology to Dr. Terri DeNeui and Dan DeNeui of EVEXIAS Health Solutions

SOUTHLAKE, Texas, May 24, 2022 (GLOBE NEWSWIRE) -- People who pursue hormone replacement therapy are seeking a happier, healthier life. The goal of practitioners who offer hormone pellet therapy is...